MDT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 7, 2022 in the Class Action Filed on Behalf of Medtronic plc Shareholders

NEW YORK, Oct. 25, 2022

This lawsuit is on behalf of persons and entities who purchased or otherwise acquired Medtronic common stock between June 8, 2019, and May 25, 2022, inclusive.
Lead Plaintiff Deadline: November 7, 2022
No obligation or cost to you.

Learn more about your recoverable losses in MDT:
https://www.kleinstocklaw.com/pslra-1/medtronic-class-action-submission-form?id=32942&from=4

Medtronic plc NEWS - MDT NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Medtronic plc made materially false and/or misleading statements and/or failed to disclose that: (1) Medtronic's product quality control systems were inadequate; (2) Medtronic had failed to comply with numerous regulations regarding risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events; (3) these failures increased the risk of regulatory investigation and action; (4) as a result of the Company's misconduct, the U.S. Food and Drug Administration would delay the approval of additional Medtronic MiniMed devices, including the MiniMed 780G; (5) these delays in product approvals, as well as the Company's need to improve its quality control systems, would negatively affect the Company's financial performance and cause Medtronic to fall further behind its competitors; and (6) as a result of the foregoing, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Medtronic you have until November 7, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Medtronic securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.